As our approach to the search for antigens which might be included when designing a synthetic anti-tuberculosis vaccine has been based on results obtained so far regarding the malaria model, it is proposed here that HABP structures must be modified by specifically replacing aa in the peptides' original sequences. The gene discussed is HABP2; the disease is tuberculosis.